VALACYCLOVIR DIN 02442000
Status: Marketed
Holder: SIVEM PHARMACEUTICALS ULC
Health Canada record
| Active ingredient(s) | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J05AB11 VALACICLOVIR |
| Original market date | 14-Oct-2015 |
| Current status date | 04-May-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sivem Pharmaceuticals ULC — licence 101965, currently licensed, last inspection rating C (2025-02-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02563622 | AG-VALACYCLOVIR | ANGITA PHARMA INC. | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 1000 MG | Approved |
| 02500582 | AG-VALACYCLOVIR | ANGITA PHARMA INC. | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Marketed |
| 02354705 | APO-VALACYCLOVIR | APOTEX INC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 1000 MG | Marketed |
| 02295822 | APO-VALACYCLOVIR | APOTEX INC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Marketed |
| 02405040 | AURO-VALACYCLOVIR | AURO PHARMA INC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Marketed |
| 02405059 | AURO-VALACYCLOVIR | AURO PHARMA INC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 1000 MG | Marketed |
| 02558858 | JAMP VALACYCLOVIR | JAMP PHARMA CORPORATION | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 1000 MG | Marketed |
| 02440598 | JAMP VALACYCLOVIR | JAMP PHARMA CORPORATION | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Marketed |
| 02351560 | MYLAN-VALACYCLOVIR | MYLAN PHARMACEUTICALS ULC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 1000 MG | Marketed |
| 02351579 | MYLAN-VALACYCLOVIR | MYLAN PHARMACEUTICALS ULC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Marketed |
| 02558149 | NB-VALACYCLOVIR | NB PHARMA INC. | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 1000 MG | Approved |
| 02558130 | NB-VALACYCLOVIR | NB PHARMA INC. | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Marketed |
| 02298457 | PMS-VALACYCLOVIR | PHARMASCIENCE INC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Marketed |
| 02381230 | PMS-VALACYCLOVIR | PHARMASCIENCE INC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 1000 MG | Marketed |
| 02315173 | PRO-VALACYCLOVIR | PRO DOC LIMITEE | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Marketed |
| 02316447 | RIVA-VALACYCLOVIR | LABORATOIRE RIVA INC. | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Marketed |
| 02357534 | TEVA-VALACYCLOVIR | TEVA CANADA LIMITED | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Marketed |
| 02454645 | VALACYCLOVIR | SANIS HEALTH INC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Marketed |
| 02553511 | VALACYCLOVIR | SIVEM PHARMACEUTICALS ULC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 1000 MG | Marketed |
| 02519585 | VALACYCLOVIR | SANIS HEALTH INC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 1000 MG | Marketed |
| 02246559 | VALTREX | GLAXOSMITHKLINE INC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 1000 MG | Marketed |
| 02219492 | VALTREX | GLAXOSMITHKLINE INC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Marketed |
| 02444860 | BIO-VALACYCLOVIR | BIOMED PHARMA | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Cancelled Post Market |
| 02331756 | CO VALACYCLOVIR | COBALT PHARMACEUTICALS COMPANY | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 1000 MG | Cancelled Pre Market |
| 02331748 | CO VALACYCLOVIR | COBALT PHARMACEUTICALS COMPANY | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Cancelled Post Market |
| 02307936 | DOM-VALACYCLOVIR | DOMINION PHARMACAL | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Cancelled Post Market |
| 02441454 | JAMP-VALACYCLOVIR | JAMP PHARMA CORPORATION | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Cancelled Post Market |
| 02441586 | MAR-VALACYCLOVIR | MARCAN PHARMACEUTICALS INC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Cancelled Post Market |
| 02307944 | PHL-VALACYCLOVIR | PHARMEL INC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Cancelled Post Market |
| 02441861 | PRIVA-VALACYCLOVIR | PHARMAPAR INC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Cancelled Post Market |
| 02357542 | TEVA-VALACYCLOVIR | TEVA CANADA LIMITED | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 1000 MG | Cancelled Pre Market |
| 02442019 | VALACYCLOVIR | SIVEM PHARMACEUTICALS ULC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 1000 MG | Cancelled Post Market |
| 02320916 | VALACYCLOVIR | SORRES PHARMA INC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Cancelled Pre Market |
| 02444720 | VAN-VALACYCLOVIR | VANC PHARMACEUTICALS INC | Tablet | VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 20108 | 2017-11-30 | Abbreviated New Drug Submission (ANDS) | Administrative: Licensing agreement between two companies |
| 17376 | 2015-10-14 | Abbreviated New Drug Submission (ANDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |